Program #862 • Available Wednesday, February 28, 2007
Certified for AMA PRA Category 1 Credit™ through Sunday, February 28, 2010

HCV and HIV Coinfection

 

Program Description

More than 170 million people worldwide have chronic hepatitis C virus (HCV) infection and approximately 40 million individuals are infected with the human immunodeficiency virus (HIV). Coinfection with HIV and HCV is common and affects 15% to 30% of HIV-infected individuals in the United States. Immunosuppression can increase the risk of progressive liver disease in HIV patients coinfected with HCV. In addition, coinfected patients are 3 times more likely to develop cirrhosis and 4.6 times more likely to die of liver disease than are individuals infected with HIV alone. In this program, Dr. Polsky discusses evidence-based strategies for optimizing the management of patients coinfected with HCV and HIV.

( minutes)

Credit Information

Up to 1 AMA PRA Category 1 Credit™

This activity is designed for primary care physicians and other interested healthcare professionals.

Learning Objectives

After taking part in this CME activity, participants should be able to:

CME Credit Designations

ACCME The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA NCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP This activity has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Thursday, February 28, 2008. Term of approval is for one year from this date, with option for yearly renewal.

AOA This activity is eligible for up to 1 hour of credit in Category 2-A of the American Osteopathic Association.